Lasting Outcome Similar for ULS, SSLF for Pelvic Organ Prolapse

Share this content:
Lasting Outcome Similar for ULS, SSLF for Pelvic Organ Prolapse
Lasting Outcome Similar for ULS, SSLF for Pelvic Organ Prolapse

TUESDAY, April 17, 2018 (HealthDay News) -- For women with pelvic organ prolapse, there is no significant difference in five-year outcomes with uterosacral ligament suspension (ULS) and sacrospinous ligament fixation (SSLF) surgeries, and no difference in the success of perioperative behavioral therapy and pelvic floor muscle training (BPMT) or usual care, according to a study published in the April 17 issue of the Journal of the American Medical Association.

J. Eric Jelovsek, M.D., from the Cleveland Clinic, and colleagues conducted a 2 × 2 factorial randomized clinical trial at nine U.S. medical centers. Women were randomized to BPMT or usual care (186 and 188 women, respectively), or to surgical interventions: ULS or SSLF (188 and 186 women, respectively).

The researchers found that the estimated surgical failure rate was 61.5 and 70.3 percent in the ULS and SSLF groups, respectively (adjusted difference, −8.8 percent; 95 percent confidence interval, −24.2 to 6.6), by year five. The estimated anatomic failure rate was 45.6 and 47.2 percent in the BPMT and usual care groups, respectively (adjusted difference, −1.6 percent; 95 percent confidence interval, −21.2 to 17.9). Improvements in the Pelvic Organ Prolapse Distress Inventory scores were −59.4 and −61.8 in the BPMT and usual care groups, respectively (adjusted mean difference, 2.4; 95 percent confidence interval, −13.7 to 18.4).

"Compared with outcomes at two years, rates of surgical failure increased during the follow-up period, although prolapse symptom scores remained improved," the authors write.

Several authors disclosed financial relationships with UpToDate.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »